Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via your Society

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About

YouTube

Podcasts

Zoom Journal Club
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens
Log in via your Society

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

second line therapy

Is combination chemotherapy superior to single-agent chemotherapy in second-line treatment?
A. González-Martín

International Journal of Gynecologic Cancer Oct 2003, 13 (Suppl 2) 185-191; DOI: 10.1136/ijgc-00009577-200311001-00010
The use of continuous infusion topotecan in persistent and recurrent ovarian cancer
J. C. Elkas, C. H. Holschneider, B. Katz, A. J. Li, R. Louie, K. F. Mcgonigle, J. S. Berek

International Journal of Gynecologic Cancer Feb 2003, 13 (2) 138-141; DOI: 10.1136/ijgc-00009577-200303000-00006